---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-217302"
form_type: "8-K"
ticker: "OVID"
cik: "0001636651"
company_name: "Ovid Therapeutics Inc."
filed_at: "2024-09-11T23:59:59+00:00"
generated_at: "2026-05-31T05:27:08.394689+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Ovid Therapeutics appoints Meg Alexander as President and COO effective Sept 9

## Summary
- Annual base salary of $500,000; target bonus of 45% of base salary.
- Granted option to purchase 140,000 shares at $1.07 per share, 10-year term.
- Option vests 25% on one-year anniversary, then monthly over 36 months.
- Severance includes 12 months salary and COBRA gross-up on covered termination.
- Alexander previously served as Chief Strategy Officer since June 2023.

## SEC filing metadata
- accession: 0001193125-24-217302
- form_type: 8-K
- ticker: OVID
- cik: 0001636651
- company_name: Ovid Therapeutics Inc.
- filed_at: 2024-09-11T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636651/000119312524217302/0001193125-24-217302-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636651/000119312524217302/d869021d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-217302
- JSON: https://secwatch.observer/filing/0001193125-24-217302.json
- Plain text: https://secwatch.observer/filing/0001193125-24-217302.txt

## Key facts
- Executive change
  Margaret "Meg" Alexander was appointed as President and Chief Operating Officer at Ovid Therapeutics Inc..
  - Action: appointed
  - Role: President and Chief Operating Officer
  source text: On September 8, 2024, the Board of Directors of Ovid Therapeutics Inc. (the “Company”) appointed Margaret “Meg” Alexander, the Company’s Chief Strategy Officer, to President and Chief Operating Officer (“COO”) of the Company, effective September 9, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1636651/000119312524217302/0001193125-24-217302-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.